[Targeting of doxorubicin to the tumor vascular system].
Jeanteur
P
P
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001435:Bacteriophages; D004317:Doxorubicin / Q000008:administration & dosage*; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D000922:Immunotoxins; D004317:Doxorubicin